Xenon Pharmaceuticals Inc (XENE) Financials
Key financial figures for Xenon Pharmaceuticals Inc (Q1 2026).
- Revenue
- $0
- Net Income
- -$102M
- EPS
- $-1.17
- Total Assets
- $1.4B
- Operating Cash Flow
- -$89M
Full income statement, balance sheet, and cash flow for Xenon Pharmaceuticals Inc on SentiSense.